相关实验视频
Updated: Jan 9, 2026

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
746
医院前使用阿司匹林与肺栓塞的改善临床结果有关:一项回顾性病例控制研究
Mithil Gowda Suresh1, Safia Mohamed2, Harinivaas Shanmugavel Geetha1
1Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01608, United States.
World journal of cardiology
|December 8, 2025
概括
医院前使用阿司匹林可以降低肺栓塞 (PE) 的严重程度和死亡率. 这项研究表明阿司匹林可以提供预防PE并发症的保护,这需要进一步调查.
科学领域:
- 心脏病学 心脏病学
- 肺部医学 肺部医学
- 血栓塞栓性疾病 血栓塞栓性疾病
背景情况:
- 肺栓塞 (PE) 是心血管死亡的重要原因之一.
- 抗凝药是标准的PE治疗方法,但阿司匹林在血栓炎症中的作用还没有得到充分研究.
- 在非手术性PE患者中调查医院前阿司匹林的使用是至关重要的.
研究的目的:
- 确定医院前阿司匹林使用是否与急性PE患者的更好的结果相关.
- 分析阿司匹林使用和PE严重性标志物之间的关联.
- 评估阿司匹林对重症监护入院和PE死亡率的影响.
主要方法:
- 对323名CT确诊急性PE的成年患者进行了回顾性病例控制研究 (2020年1月至2023年12月).
- 根据记录的每日阿司匹林使用情况 (治疗前≥7天) 将患者分组为组.
- 评估结果:右心室应变,ICU入院,休克,机械通风和住院死亡率.
主要成果:
- 90名患者 (27.9%) 使用了医院前的阿司匹林;他们年龄较大,患冠状动脉疾病较多.
- 阿司匹林使用与显著较低的右心室应变率 (22.2%与34.8%) 有关.
- 前往医院服用阿司匹林与减少ICU入院 (16.7%与28.8%相比),休克 (2.2%与9.9%) 和住院死亡率 (3.3%与11.6%) 有关.
结论:
- 医院前使用阿司匹林与急性PE的严重性和死亡率降低有关.
- 结果表明阿司匹林在PE管理中具有潜在的保护作用.
- 建议在未来的多中心试验中进行进一步验证.
相关概念视频
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
281
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
281
Pulmonary Embolism III: Nursing Management
325
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
325
Pulmonary Embolism I: Introduction
471
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
471
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
439
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
439
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Venous Thrombosis III: Interprofessional Care
265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
